Modulation of cardiometabolic risk and CardioRenal syndrome by oral vitamin D(3) supplementation in Black and White Southern Sahara residents with chronic kidney disease Stage 3: focus on racial and ethnic disparities

OBJECTIVES: Several studies have shown that cholecalciferol supplementation (25OHD-S) in chronic kidney disease (CKD) improves kidney injury by reducing fibrosis-related vascular calcification and declining apoptosis-linked nephron damage. METHODS: The oral 25OHD-S was evaluated in 60,000 IU/month/3...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouazza, Asma, Tahar, Amina, AitAbderrhmane, Samir, Saidani, Messaoud, Koceir, Elhadj-Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359195/
https://www.ncbi.nlm.nih.gov/pubmed/35930297
http://dx.doi.org/10.1080/0886022X.2022.2106244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359195/
https://www.ncbi.nlm.nih.gov/pubmed/35930297
http://dx.doi.org/10.1080/0886022X.2022.2106244

Ejemplares similares